These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6694805)

  • 1. The Walton report and its subsequent impact on cervical cancer screening programs in Canada.
    Worth AJ
    Obstet Gynecol; 1984 Feb; 63(2):135-9. PubMed ID: 6694805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening programs: summary of the 1982. Canadian task force report.
    Can Med Assoc J; 1982 Oct; 127(7):581-9. PubMed ID: 7127225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening: précis and critique of a recent Canadian report.
    Chiavetta J; Leader SR
    Med J Aust; 1977 Jan 1-8; 1(1-2):23-8. PubMed ID: 840075
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the Walton report on cervical cancer screening programs in Canada.
    Kassirer E
    Can Med Assoc J; 1980 Feb; 122(4):417-23. PubMed ID: 7370844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from a cervical cancer screening programme in Manitoba, Canada.
    Choi NW; Nelson NA
    IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the Leiden mass screening for cervix uteri carcinoma; the 'young' (24-34 years) versus the 'old' (35-54 years) group of women].
    Boon ME; de Graaff Guilloud-Gentenaar JC; Beck S
    Ned Tijdschr Geneeskd; 1990 Aug; 134(32):1545-9. PubMed ID: 2392176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Screening for cervical cancer.
    Lancet; 1974 Jun; 1(7868):1221. PubMed ID: 4134347
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the impact of screening for cancer of the cervix.
    Miller AB
    IARC Sci Publ; 1986; (76):149-60. PubMed ID: 3570400
    [No Abstract]   [Full Text] [Related]  

  • 10. Cervical cancer screening programs. I. Epidemiology and natural history of carcinoma of the cervix.
    Can Med Assoc J; 1976 Jun; 114(11):1003-12. PubMed ID: 776378
    [No Abstract]   [Full Text] [Related]  

  • 11. Cervical cytology in Greenland and occurrence of cervical carcinoma, carcinoma in situ, and dysplasia. Extent and impact of uncoordinated screening activity 1976-1985.
    Højgaard Nielsen N; Jensen H; Hansen PK
    Arctic Med Res; 1988 Oct; 47(4):179-88. PubMed ID: 3214508
    [No Abstract]   [Full Text] [Related]  

  • 12. A cohort study of cervical cancer screening in British Columbia.
    Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
    Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
    [No Abstract]   [Full Text] [Related]  

  • 13. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982].
    Klinkhamer PJ; van der Graaf Y; Vooijs GP
    Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185
    [No Abstract]   [Full Text] [Related]  

  • 16. [A retrospective study of carcinoma of the uterine cervix and the value of cytological cervix studies in healthy women].
    Barentsz JO; Muizebelt F; van der Schee AC; Toonen-van Beek AA
    Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1932-6. PubMed ID: 514382
    [No Abstract]   [Full Text] [Related]  

  • 17. Arkansas cervical cancer program.
    Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
    J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
    Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
    Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of cervical cancer at the Bell Telephone Company of Canada (1965-1969)].
    Audet-Lapointe P
    Union Med Can; 1972 Dec; 101(12):2713-6. PubMed ID: 4661704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.